WELL Health 2026 Plan Highlights Tech Platform Growth And Clinic Execution
WELL Health Technologies (TSX:WELL) CEO issued a shareholder letter outlining the company’s outlook and growth priorities for 2026. The letter...
Execution
Visionary Holdings (Nasdaq: GV) Appoints CEO of Health Technology Business, Establishes New Sales Entity in Nanjing to Accelerate Commercial Execution in China Market
HONG KONG, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (“GV” or the “Company”), a technology-driven multinational enterprise listed...
Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease
Vivoryon Therapeutics N.V.Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to...
